|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Cellular and Molecular Medicine, Kidney Research Centre, University of Ottawa, Ottawa, ON, Canada
* To whom correspondence should be addressed. E-mail: rlhebert{at}uottawa.ca.
Mesangial cells (MG) are an important source of renal PGE2 and PGI2. The purpose of
this study was to examine the effects of cicaprost (CCP: PGI2 analogue) on MG function, and the expression of IP receptors in streptozotocin (STZ)-diabetic rats and glucose-treated MG cells. CCP increased cellular cAMP in immortalized rat MG cells. Both glucose and anisomycin attenuated CCP-cAMP, but not phorbol-myristate-acetate, angiotensin II, or transforming growth
factor-
. Also, IP receptor protein was reduced in response to glucose. While CCP decreased the levels of the cell cycle inhibitor p27, it did not alter thymidine or leucine incorporation. However, CCP reduced fibronectin levels by 40 %, and increased matrix metalloproteinase-2
levels by 3- fold, a key enzyme in matrix degradation. Finally, IP receptors were significantly reduced in outer medulla of 4 and 12 wks STZ-diabetic rats; and in the cortex, outer, and inner medullary regions in 6-mth uni-nephrectomized STZ-diabetic rats. The changes in the CCP/IP
system observed in this study suggest that IP may serve as an alternate therapeutic target in diabetes.
This article has been cited by other articles:
![]() |
R. Nasrallah, H. Xiong, and R. L. Hebert Renal prostaglandin E2 receptor (EP) expression profile is altered in streptozotocin and B6-Ins2Akita type I diabetic mice Am J Physiol Renal Physiol, January 1, 2007; 292(1): F278 - F284. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zhang, Z. Dong, and T. Yang Prostaglandin D2 inhibits TGF-beta1-induced epithelial-to-mesenchymal transition in MDCK cells Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1332 - F1342. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Xiang, J. S. Naik, B. L. Hodnett, and R. L. Hester Altered arachidonic acid metabolism impairs functional vasodilation in metabolic syndrome Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R134 - R138. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Nasrallah and R. L. Hebert Prostacyclin signaling in the kidney: implications for health and disease Am J Physiol Renal Physiol, August 1, 2005; 289(2): F235 - F246. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |